Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction.

Oncotarget · 2016 · PMC5342457 · PMID 27323834

Europe PMC DOI

hedged sentence

0.0100

closest p · 0.2× alpha

0.0100

boldest claim

The sentences

highly significantp =0.01actually significant

Patients receiving Epidiolex achieved a highly significant 39% median monthly reduction in convulsive seizures compared with a 13% reduction in those receiving a placebo ( p =0.01).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.